Skip to main content
Clinical Trials/JPRN-UMIN000049108
JPRN-UMIN000049108
Completed
未知

Effects of consumption of the test food on appetite in healthy Japanese subjects: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Effects of consumption of the test food on appetite in healthy Japanese subjects

ORTHOMEDICO Inc.0 sites46 target enrollmentDecember 20, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Japanese subjects
Sponsor
ORTHOMEDICO Inc.
Enrollment
46
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 20, 2023
End Date
December 21, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5\. Subjects who are currently taking medications (including herbal medicines) and supplements 6\. Subjects who are allergic to medicines and/or the test food related products 7\. Subjects whose score of the Council of Nutrition Appetite Questionnaire (CNAQ\-J) is 16 or less 8\. Subjects whose BMI has increased or decreased by 10% or more within the last three months 9\. Subjects who work in the late\-night shift or in shifts at least once weekly 10\. Subjects who work with driving vehicles or operating machinery accompany by danger 11\. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 12\. Subjects who suffer from COVID\-19 13\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 14\. Subjects who are judged as ineligible to participate in this study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials